INQOVI

Serial Number 79282613
Registration 6177299
700

Registration Progress

Application Filed
Feb 12, 2020
Under Examination
Approved for Publication
Aug 4, 2020
Published for Opposition
Aug 4, 2020
Registered
Oct 20, 2020

Attorney Assistance

Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20201020)
Due: Oct 20, 2026 301 days

Trademark Image

INQOVI

Basic Information

Serial Number
79282613
Registration Number
6177299
Filing Date
February 12, 2020
Registration Date
October 20, 2020
Published for Opposition
August 4, 2020
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 20, 2020
Registration
Registered
Classes
005

Rights Holder

TAIHO PHARMACEUTICAL CO., LTD.

99
Address
1-27 Kandanishiki-cho,
Chiyoda-ku Tokyo 101-8444
JP

Ownership History

Otsuka Pharmaceutical Co., Ltd.

Original Applicant
03
JP

Otsuka Pharmaceutical Co., Ltd.

Owner at Publication
03
JP

Otsuka Pharmaceutical Co., Ltd.

Original Registrant
03
JP

TAIHO PHARMACEUTICAL CO., LTD.

New Owner After Registration #1
99
JP

USPTO Deadlines

Next Deadline
301 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20201020)
Due Date
October 20, 2026
Grace Period Ends
April 20, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Oct 20, 2025 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Mar 26, 2024 CHLD M CHANGE OF OWNER RECEIVED FROM IB Loading...
Mar 1, 2021 FINV P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Feb 10, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Feb 10, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jan 20, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Oct 20, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 4, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 4, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 31, 2020 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jul 15, 2020 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jul 15, 2020 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jul 15, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 30, 2020 ALIE A ASSIGNED TO LIE Loading...
Jun 29, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 29, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 28, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 28, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 29, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
May 14, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 14, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
May 2, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
May 1, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 30, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 24, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 20, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 14, 2020 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Apr 9, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for treating cancer; pharmaceutical preparations for treating immune disorders; pharmaceutical preparations for treating hematological disorders

Additional Information

Design Mark
The mark consists of the stylized wording "INQOVI" with the letter "O" in black, green and orange and the remaining letters in black.
Color Claim
The color(s) black, green and orange is/are claimed as a feature of the mark.

Classification

International Classes
005